AbbVie
AbbVie is an Illinois-based pharmaceutical company that develops and markets medicinal drugs for the treatment of diseases such as neuroscience and oncology.
Business Model:
Revenue: $56.7B
Employees: 10,001-999,999
Rankings
Industries / Tags:
Detailed AbbVie Information
Geographic Data
Address: 1 North Waukegan Road
City: North Chicago
State: IL
Zip: 60064
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$6B
Social
Metrics
102,291Website Global Rank
963,934Website Monthly Traffic
Twitter Followers
Description
AbbVie is an Illinois-based pharmaceutical company that develops and markets medicinal drugs for the treatment of diseases such as neuroscience and oncology.
Contact Phone:
+18479327900
Contact Email:
AbbVie went public on 12/21/2012 on the NYSE
Listed Exchange:
NYSE
IPO Date:
12/21/2012
Ticker Symbol:
ABBV
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2017 | Aquinnah Pharmaceuticals | Equity | 10M |
| 8/2021 | Eskenazi Health | Grant | - |
| 12/2020 | Year Up | Grant | 10M |
| 12/2018 | St Jude Children’s Research Hospital | Grant | 0 |
| 4/2021 | Capsida | Corporate Round | 90M |
| 12/2019 | Inventiva Pharma | Grant | 0 |
| 6/2021 | Kojin Therapeutics | Series A | 60M |
| 1/2016 | Lodo Therapeutics | Series A | 0 |
| 9/2022 | Carisma Therapeutics | Series C | 0 |
| 1/2016 | Petra Pharma | Series A | 48M |
| 8/2021 | Eskenazi Health | Grant | - |
| 6/2021 | Kojin Therapeutics | Series A | 0 |
| 4/2021 | Capsida | Corporate Round | 0 |
| 12/2020 | Year Up | Grant | 0 |
| 12/2019 | Inventiva Pharma | Grant | 0 |
| 12/2018 | St Jude Children’s Research Hospital | Grant | 0 |
| 4/2017 | Aquinnah Pharmaceuticals | Venture Round | 0 |
| 1/2016 | Lodo Therapeutics | Series A | 0 |
| 1/2016 | Petra Pharma | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2019 | Debt | $6B |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 3/2022 | Syndesi Therapeutics | |
| 3/2021 | Mitokinin | |
| 7/2019 | Mavupharma | |
| 6/2019 | Allergan | |
| 4/2016 | Stemcentrx | |
| 3/2015 | Pharmacyclics | |
| 1/2014 | ImmuVen |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
